@
cherry88 Will Matrix also involve in healthcare in a big way ? then it will limit up like Mah Sing.
19/10/2020 4:53 PM

Actually it has, it is also involved in education. As for its reputation being very bad - that remains to be seen.

Watch the trend of selling. A real master at work.

Gone with the wind if you purchased this

Goreng down now. Scalping in progress. Same trend happened between 8 and 13 Oct ending in new lows. See profit, take profit. Dont be greedy and get caught

@MCDIDDY HWGB IS THE REAL KING. FORGET ABOUT SOLUTN AND BINTAI.
19/10/2020 11:03 AM

Yes, but you forgot Kanger

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30831-8/fulltext

This is the latest from The Lancet. Can anyone verify if the study conducted was under the same organisation which Kanger was earlier reported to have collaboration with in the story below?

https://www.theedgemarkets.com/article/kanger-collaborate-sinopharm-distribution-covid19-vaccine%C2%A0 - Sept 29 story

I think China will see its wish of producing vaccine for the good of humanity come true. This will be its present to the US that has been continually critical of it for the virus. If China vaccine proves without side effects and can alleviate some of the Covid 19 symptoms, then it could bring enough goodwill that may translate into other trade benefits

If HWGB breaks 79sen next week, it will be comfortable in its retracement upwards - which means at its high of 1.36 on August 25. The rise in potential will depend on how fast its other vaccine venture is coming along. From what is know, the company is quite active in making alliances at strategic places, so you can rest assured that at least the company is responding to what investors are looking for or interested in. If you study Bintai, this stock is at least pursuing aggressively its end product. So that you roughly know what you are buying into

HWGB's partner is listed on the Shenzhen Stock Exchange under CNI Biomedicine I think. Look up its stock and see that it has grown over 24% since last five months and still climbing. Congrats all who are on this wagon.

@
malysiabolehhh http://hwgbbiotech.com/news/view_news.php?news_id=84

Now this turns the tide. While Bintai Kinden has practically nothing to show, HWGB has already one in the bag. Its venture with Wuhan Easydiagnosis Biomedicine Co Ltd with the test kits which has met MOH approvals means it can distribute it here - and overseas in neighbouring countries using that testimonial as backing. If its venture bears fruit, we are looking at a runaway locomotive. Prior, we are still talking about heresay. This is news. Buy on news, they say?

Yesterday Appasia broke the psychological resistance of 0.575. Strong fund support pushed it to today's level, and I believe momentum is strong enough to crack at 0.675 next. Once this is broken, it will scale new heights befitting its expected results for the next quarter

Malaysia just joined Covac. Looks like when vaccine is ready, only one of two Government appointed firms will benefit. Unless those purported vaccine manufacturers that have joined venture with our local companies can really produce a viable vaccine. If not, a lot of investors will be caught. So, if you are investing in vaccine counters per see, please keep a sharp eye on all the details if you have a lot running. If not, slow sell may see a huge wipe-out of what you put in.

@JXnotJAX don't worry, will slowly up, this not goreng counter

Only those who are caught buying via rumours and had to sell are becoming sour. If you know what you are investing, then there is little worry. Only when you are unsure and do not have a strong foundation will your feet sway even at the slightest fart sound

Yes, but take this statement as a caution. We are investing, not throwing salt into sea.

"We are following closely on the developments in this CRUCIAL venture of our healthcare business as we want to do our bit in helping to combat the virus that has affected the health of so many, including their livelihoods and income,” Dato’ Aaron Lim said."

Meaning if it doesn't get through, HWGB is in deep sea. Just follow developments closely. There are currently 162 possible candidates in different stages of trials. Only the Chinese claim that theirs are at the final stages and already on thousands of human trials.US based ones are more stringent . Eli Lilly just halted testing because of one unexplained health issue of one of its respondents. As a result, EL shares were dropped cold.

No politician will admit owning any public company, let's face it. But when it comes to an election, one wonders where money will come from - certainly not well-wishers who just throw cash into the coffers without looking for goodwill.

Anyone know how this vaccine is going to be like or is there any information? How will it be distributed and who will have final say in the distribution? In vaccine investment - it is a 50-50 thing. This counter is better than Bintai in the sense that it has inked many JVs with companies in the study and making of vaccines. But there is a ceiling price for all stocks for all it's worth. Continuously chasing its high will end up being caught by smartmoney who has better and faster data than the common people in the streets like you and me who depend on rumours. Those who do more research will benefit and they may share with you their findings - AFTER they already bought into the market. So, watch this stock at its current high price. If you have profited, good. If not, a wait may not be a bad thing. Until someone finds an effective vaccine, any rumour is only as good as coffeeshop talk

Did you realise that PRDM no longer allows you to use MyEg to pay summons? There is one big chunk of business gone. How many will follow? I think this sorts of average out whatever it will be doing

better keep shares - when is exit date

Yes, even Ely Lilly has halted because of safety issues. Generex if it is anywhere near development an effective vaccine would have flown sky high and drag Bintai with it. So far, it is mere speculation that is maintaining the Bintai prices now.

It wont have limit up. This business is also quite competitive. What will happen is probably profit taking. See how much selling there was at 1.15-1.16, I think it may drop back to 1.10 or lower before heading up again. Good news is the company is acquiring premises to increase its production footprint but results will only be seen after the factories are built and possibly show results in two or more quarters

Not good:

https://codeblue.galencentre.org/2020/10/08/malaysian-engineering-company-signs-deal-for-covid-vaccine-with-unknown-clinical-research/

@Avalon88
Thanks for your analysis. Commonsense will also tell us that left hand is selling to right when and when it's done enough, one hand will be removed to that people will chase next level. There is nothing from this company that warrants positivity let alone confidence

Soar up? Heikin Ashi is not foolproof. You need others - even with MACD, it does not show much. Right now, it's just predictable play from 0.035 to 0.04 and back. As long as there is no institutional funds looking at this stock, only retailers will play for shorts and you end up caught most of the time if you are not careful

Check its PE. So far, projected earnings are from the e.Confirm and Yellow Pages. If new projects are announced, then to may shoot higher than the 90sen level previously held. If not wait for third week of Nov when the quarter results are out. This should show positive signs

Those with funds are playing on small fry - they block either way to prevent rise or fall and psychologically force the greedy ones to buy or sell.

@amithaba this gnbt and bintai is trying to make news using social media to goreng their share only...very old tricks.
08/10/2020 3:53 AM

there is a taker every day and so you see those who do not do research end up winning on bet and losing the other nine

As long as there is no concrete news, it will be 62-68sen play, up and down. Who is smart, they don't get caught.

@KLLee_0110 Bintai shouldn’t below RM1.
07/10/2020 9:31 AM

What do you based this assumption on?

Where are the data supporting that a vaccine is already on hand with Generex? All I read are appoints of board members to supervise its development (only now?) and MoUs signed with other companies, including Bintai. GNBT is still very suppressed in price. Until that one flies, be reserved about this stock.

@
Avalon88 https://www.google.com/amp/s/www.nst.com.my/amp/business/2020/06/60445...

Old news. When it went up, after that, price already reflected - then it crashed and burned

There are no good news, what to expect? It will not go up any higher than 7sen.

@
KLLee_0110 If vaccine coming in Bintai will be the first get the pririoty
05/10/2020 10:52 AM

Where did you get this information?

Just heard - Sabah hospitals would need additional beds to house increasing number of patients. This should be good news for LKL.

such low volume and retailers are pushing it down for the benefits of bigger players if they come in later

Read this to understand more:

"Currently, there are no effective vaccines for the prevention of COVID-19. But, few candidates moved into clinical trial.

CanSino Biologicals started Phase 2 clinical trial in China (NCT04341389) for Ad5- nCoV which showed safe, tolerable and immunogenic in phase 1 clinical trial. Moderna Announces Positive Interim Phase 1 Data for mRNA-1273 vaccine. The vaccine elicited virus- neutralizing antibodies at the levels displayed in convalescent sera and showed full protection against viral replication in the lungs in a mouse model. The vaccine candidate mRNA-1273 also showed safe and well tolerated.

Inovio Pharmaceutical developed INO-4800 which is in phase 1 trials showed safe and protective immunity. LV- SMENP- DC from Shenzhen Geno-Immune Medical Institute (phase1) may offer promising vaccines against COVID-19.

University of Oxford developed a vaccine based on Chimpanzee Adenovirus Vector (ChAdOx1) which is immunogenic in mice. The vaccine candidate entered phase I/II (NCT04324606) clinical trial in April 2020 to study its safety, tolerability and immunogenicity in 510 volunteer."


Also read the part about Synthetic Peptide or Epitope Vaccine and its effectiveness.



Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293477/

@
Sneakpeek This is the time to sell hospital beds to Azerbaijan and Armenia.. expand export market
02/10/2020 10:54 AM

Who knows - like I said, maybe big news coming? See the accumulation trend today?

Institutional funds and smartmoney are in. 1.125 next stop

Big news coming? Wow!

Warrant holders can kiss their $$ goodbye

@zhm540 be realistic... high profile government unit IJN will not signed MOU with Bintai if Bintai agreement with Generex is dubious....
01/10/2020 10:49 AM

It is just an MoU. Nothing concrete. Where is the vaccine? If there is a vaccine being developed by Generex, how is it that the stock is still stuck at where it is now? Wouldnt competitors' companies be buying into Generex if they are aware that a possibly effective vaccine is being developed? No investor is that dumb not to invest if they knew something so obvious, especially when in Covid season, not much investment elsewhere is profitable. I say watch first - even at 0.57, the price is too high. It was speculated from 0.31 when news got out and people rushed in to just chase.

I will not reenter until something concrete comes out from Bintai BOD. They must include: 1) stage of the vaccine development 2) any further MoUs leading to its anticipated distribution nationwide and elsewhere, and 3) its coming quarterly report versus share value

Depends on what is your entry. If you entered in early July before the launched eConfirm and prices shot up, then it is still okay. it's still 70% profit.

Read this - This is Generex deal with Chinese companies. Look at the terms of agreement and see if it is similar to what we see with Bintai

https://www.newsbreak.com/news/1516989631792/the-steady-rise-of-generex-biotechnology-corporation-otcmktsgnbt

Good idea, but what if they cant find a vaccine and Bintai exercise its first rights of refusal - they don't even have to apologise to shareholders because investments come with caveats. This is one of them.

@amithaba this is the further prove that thisGNBT does not had the ability to make the effective covid 19 vaccine......a lot of people here comment us to buy this bintai shit caused they had brought the share above rm0.70 else they are bintai worker....so,sell now.

Any vaccine research and development takes time and most of all money. GNBT if it has the technology, big names will likely prop up its stock prices. Imagine you own a drug company and you find that your competitor has capability to produce a drug sorely needed. Wont you just buy as many stocks from the market so that you get your toe, and eventually your feet into it. At least if you don't have the drug, this investment will still give you returns your shareholders will thank you for. But following GNBT's stock movement, this has not happened - otherwise the price wont be sliding so noticeably over the years. We are so far away - likely if they have anything, the scientific community in US would have shown their confidence in the stock price

@
warriorchan Ssm Registered Company:1,300,000 companies
Cost per submission: RM15
Assumption: minimum 1 time submissions for 1 company per yr (correct me if im wrong, im not sure too)
Sales: 1,300,000 x 15 x 1 = 19.5m
PAT: deduct 25% = 14.6m (i havent add up other's income)

Assume PE: 20 (very undervalue for a bright future tech company)

14.6/358 x 20 = 0.815

Less less also RM0.815

Correct. But you need to wait for Appasia quarterly and annual reports to come in. Wait next quarter results and then we can see the confidence around this stock. This is its reasonable current price. If you can find out how much is being held by institutional funds, then you may know whether it is a worthwhile deal from current market price.

@KLLee_0110 As for Bintai is very good news

No vaccine yet. Worse, we don't even know at what stage is the development, or if it is going for trials. This is good news?

This counter will fly to China if the vaccine Generex is building succeeds.. right now, there is nothing, Even Generex shares have been trashed.. if u want to know when to hit this stock, monitor Generex shares. The minute it turns, you can depend on hitting this Bintai with success

0.685 coming

@
jackpot8888 why is calvintaneng keep asking 'sell'? i think we all assess risk to invest and i chose to recover my capital. those wish to try at rm1, let it be. any reasons?

maybe he likes giving advice